-
Product Insights
Likelihood of Approval Analysis for Respiratory Tract Infections
Overview How likely is it that the drugs in Respiratory Tract Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Respiratory Tract Infections Overview Respiratory tract infections (RTIs) are infectious diseases...
-
Product Insights
Likelihood of Approval Analysis for Chemotherapy Induced Neutropenia
Overview How likely is it that the drugs in Chemotherapy Induced Neutropenia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chemotherapy Induced Neutropenia Overview Chemotherapy-induced neutropenia is a very common side...
-
Product Insights
Likelihood of Approval Analysis for Pheochromocytoma
Overview How likely is it that the drugs in Pheochromocytoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pheochromocytoma Overview Pheochromocytoma is a rare, usually non-cancerous (benign) tumor that develops from...
-
Product Insights
Likelihood of Approval Analysis for Allergic Rhinitis
Overview How likely is it that the drugs in Allergic Rhinitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Allergic Rhinitis Overview Allergic rhinitis is an allergic reaction that happens when...
-
Product Insights
Likelihood of Approval Analysis for Bronchitis
Overview How likely is it that the drugs in Bronchitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bronchitis Overview Bronchitis is an inflammation of the lining of bronchial tubes, which...
-
Product Insights
Likelihood of Approval Analysis for Atherosclerosis
Overview How likely is it that the drugs in Atherosclerosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Atherosclerosis Overview Atherosclerosis (or arteriosclerotic vascular disease) is a condition where the arteries...
-
Product Insights
Likelihood of Approval Analysis for Tuberculosis
Overview How likely is it that the drugs in Tuberculosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tuberculosis Overview Tuberculosis, commonly known as TB, is a bacterial infection that can...
-
Product Insights
Likelihood of Approval Analysis for Amyloidosis
Overview How likely is it that the drugs in Amyloidosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amyloidosis Overview Abnormal accumulation of amyloid protein in the tissues results in a...
-
Product Insights
Likelihood of Approval Analysis for Malignant Pleural Mesothelioma
Overview How likely is it that the drugs in Malignant Pleural Mesothelioma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Malignant Pleural Mesothelioma Overview Malignant pleural mesothelioma is a rare cancer...
-
Product Insights
Likelihood of Approval Analysis for Myocardial Infarction
Overview How likely is it that the drugs in Myocardial Infarction will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Myocardial Infarction Overview Myocardial infarction is the irreversible necrosis of heart muscle...